Home Newsletters Prostate Cell News Sonlicromanol’s Active Metabolite KH176m Normalizes Prostate Cancer Stem Cell mPGES-1 Overexpression and...

Sonlicromanol’s Active Metabolite KH176m Normalizes Prostate Cancer Stem Cell mPGES-1 Overexpression and Inhibits Cancer Spheroid Growth

0
Investigators investigated whether KH176m, a recently discovered selective mPGES-1 inhibitor, could affect prostate cancer cells-derived spheroid growth.
[PLOS One]
6445218 {6445218:Q7CEVQUB} apa 50 1 164578 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version